Discontinued — last reported Q4 '25
Corteva Interest Paid remained flat by 0.0% to $61.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $58.50M to $61.00M. Over 3 years (FY 2021 to FY 2024), Interest Paid shows an upward trend with a 101.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $30.00M | $75.00M | $234.00M | $244.00M |
| YoY Change | — | +150.0% | +212.0% | +4.3% |